BOD
Discover related
4 sources
How the databases line up — = agree, ≈ partial, ≠ differ. In lists, shared items appear in every source and unique ones in only one (matched case-insensitively).
| TripSit | Pharmacology | DailyMed | PiHKAL | ||
|---|---|---|---|---|---|
| Classification | |||||
| Class / category | — | — | — | ||
| Also known as | — | — | — | '-METHOXY-2C-D4-METHYL-2,5,'-TRIMETHOXYPHENETHYLAMINE | |
| Safety | |||||
| Dose · Oral | |||||
| Threshold | 12 mg | — | — | — | |
| Light | 15–20 mg | — | — | — | |
| Common | 20–30 mg | — | — | 15–25 mg | ≠ |
| Heavy | 30 mg+ | — | — | — | |
| Duration | |||||
| Onset | 60–120 minutes | — | — | — | |
| Total | 8–14 hours | — | — | 8–16 hours | ≠ |
| After-effects | 3–6 hours | — | — | — | |
| Pharmacology | |||||
Dose at a glance
Each database's primary-route ladder on one shared scale — see where ranges line up or shift.
Duration at a glance
Total duration on one shared scale.
TripSit summary
Beta-methoxy analogue of 2C-D, seems to be more "mild" than the likes of 2C-X and DOX compounds. Is 50/50 whether the body load is barely there, or overpowering the experience.
PiHKAL summary
This was the first compound tried in a new family built around adding an oxygen to the benzylic carbon, inspired by how the brain naturally converts dopamine to norepinephrine. The commentary is mostly about naming conventions and rationale rather than reported subjective effects.
Fact-sheets from PsychonautWiki. Harm-reduction reference only — not medical advice.